
|Videos|June 10, 2019
Dr. Debu Tripathy on Ribociclib Plus Hormone Therapy for Breast Cancer Patients
Author(s)Debu Tripathy, MD
Cancer Network spoke with Debu Tripathy, MD, Chair of Breast Medical Oncology at MD Anderson Cancer Center, on how ribociclib plus hormone therapy extends survival for patients with premenopausal advanced HR-positive breast cancer.
Advertisement
Cancer Network spoke with Debu Tripathy, MD, Chair of Breast Medical Oncology at MD Anderson Cancer Center, on how ribociclib plus hormone therapy extends survival for patients with premenopausal advanced HR-positive breast cancer.
Read more about these data here:
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Navigating ADC Sequencing Beyond the First Line in Breast Cancer
2
Lu-PSMA-617/Pembrolizumab Shows Early Efficacy in Metastatic CRPC
3
Navigating the 2026 ASCO Guideline Update on Managing Thyroid Cancer
4
Isatuximab Regimen Improves MRD Negativity in Transplant-Eligible NDMM
5





















































